The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Serum anti-Mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles implications for individualization of therapy
Abstract
BACKGROUND: Serum concentrations of anti-Müllerian hormone (AMH) correlate with oocyte yield in assisted reproduction treatment (ART) cycles, however, performance of AMH for prediction of live birth is unknown. METHODS: A total of 340 first cycle IVF/ICSI patients (median age 34.0 years, inter-quartile range 31.0-37.0 years), had basal plasma AMH and FSH measured and their predictive values for live birth and oocyte yield compared. RESULTS: AMH predicts live birth [contribution to variance (CTV) 3.84%, P < 0.001] and oocyte yield (r = 0.71, P < 0.0001, CTV 7.3%, P < 0.0001). Compared with age and FSH, AMH performs better in prediction of live births [area under receiver operating characteristic curve (AUC) 0.62, 95% CI 0.55-0.68; FSH AUC 0.42, 95% CI 0.35-0.49; age AUC 0.48, 95% CI 0.41-0.55, P = 0.0028] and excessive response to ovarian stimulation (AMH AUC 0.90, 95% CI 0.83-0.96; FSH AUC 0.32, 95% CI 0.23-0.40; age AUC 0.57, 95% CI 0.43-0.71, P < 0.001). AMH prediction of oocyte yield is independent of age (r = -0.28, P < 0.0001, CTV 1.4%, P = 0.006), however, a significant negative interaction (CTV 3.6%, P < 0.0001) exists. AMH demonstrates improved differential distributions for non-, poor, normal and excessive ovarian responses relative to FSH and age. CONCLUSIONS: Plasma AMH is a superior predictor of live birth and anticipated oocyte yield compared with FSH and age, facilitating individualization of therapy prior to first ART cycle.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
Weenen, C. (2004) · Molecular Human Reproduction · doi:10.1093/molehr/gah015 · Cited by 1,285
A systematic review of tests predicting ovarian reserve and IVF outcome
Broekmans, F. J., Kwee, J., Hendriks, D. J., Mol, B. W., & Lambalk, C. B. (2006) · Human Reproduction Update · doi:10.1093/humupd/dml034 · Cited by 1,258
Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve
van Rooij, I. A. J. (2002) · Human Reproduction · doi:10.1093/humrep/17.12.3065 · Cited by 951
Antimüllerian hormone serum levels: a putative marker for ovarian aging
de Vet, A., Laven, J. S. E., de Jong, F. H., Themmen, A. P. N., & Fauser, B. C. J. M. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02993-4 · Cited by 887
Anti-Mullerian Hormone Inhibits Initiation of Primordial Follicle Growth in the Mouse Ovary
Durlinger, A. L. L., Gruijters, M. J. G., Kramer, P., Karels, B., Ingraham, H. A., Nachtigal, M. W., Uilenbroek, J. T. J., Grootegoed, J. A., & Themmen, A. P. N. (2002) · Endocrinology · doi:10.1210/en.143.3.1076 · Cited by 843
Anti-Mullerian Hormone Attenuates the Effects of FSH on Follicle Development in the Mouse Ovary
Durlinger, A. L. L., Gruijters, M. J. G., Kramer, P., Karels, B., Kumar, T. R., Matzuk, M. M., Rose, U. M., de Jong, F. H., Uilenbroek, J. T. J., Grootegoed, J. A., et al. (2001) · Endocrinology · doi:10.1210/en.142.11.4891 · Cited by 772
Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review
Delvigne, A. (2002) · Human Reproduction Update · doi:10.1093/humupd/8.6.559 · Cited by 717
Factors that affect outcome of in-vitro fertilisation treatment
Templeton, A., Morris, J. K., & Parslow, W. (1996) · The Lancet · doi:10.1016/s0140-6736(96)05291-9 · Cited by 708
Fanchin, R. (2003) · Human Reproduction · doi:10.1093/humrep/deg042 · Cited by 624
Serum anti-Mullerian hormone throughout the human menstrual cycle
La Marca, A., Stabile, G., Artenisio, A. C., & Volpe, A. (2006) · Human Reproduction · doi:10.1093/humrep/del291 · Cited by 532
Laven, J. S. E., Mulders, A. G. M. G. J., Visser, J. A., Themmen, A. P., de Jong, F. H., & Fauser, B. C. J. M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030932 · Cited by 519
Seifer, D. B., MacLaughlin, D. T., Christian, B. P., Feng, B., & Shelden, R. M. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)03201-0 · Cited by 494
Baarends, W. M., Uilenbroek, J. T., Kramer, P., Hoogerbrugge, J. W., van Leeuwen, E. C., Themmen, A. P., & Grootegoed, J. A. (1995) · Endocrinology · doi:10.1210/endo.136.11.7588229 · Cited by 461
Morphology and Morphogenesis of the Stein-Leventhal Ovary and of So-called “Hyperthecosis”
HUGHESDON, P. E. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198202000-00001 · Cited by 429
Serum Anti-Müllerian Hormone Levels Reflect the Size of the Primordial Follicle Pool in Mice
Kevenaar, M. E., Meerasahib, M. F., Kramer, P., van de Lang-Born, B. M. N., de Jong, F. H., Groome, N. P., Themmen, A. P. N., & Visser, J. A. (2006) · Endocrinology · doi:10.1210/en.2005-1588 · Cited by 389
Clinical management of low ovarian response to stimulation for IVF: a systematic review
Tarlatzis, B. C. (2003) · Human Reproduction Update · doi:10.1093/humupd/dmg007 · Cited by 365
Hazout, A., Bouchard, P., Seifer, D. B., Aussage, P., Junca, A. M., & Cohen-Bacrie, P. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.03.061 · Cited by 317
Muttukrishna, S., McGarrigle, H., Wakim, R., Khadum, I., Ranieri, D. M., & Serhal, P. (2005) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2005.00670.x · Cited by 304
Piltonen, T., Morin-Papunen, L., Koivunen, R., Perheentupa, A., Ruokonen, A., & Tapanainen, J. S. (2005) · Human Reproduction · doi:10.1093/humrep/deh850 · Cited by 294
Follicle dynamics during ovarian ageing
Faddy, M. J. (2000) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00238-5 · Cited by 289
Basal level of anti-Müllerian hormone is associated with oocyte quality in stimulated cycles
Ebner, T., Sommergruber, M., Moser, M., Shebl, O., Schreier-Lechner, E., & Tews, G. (2006) · Human Reproduction · doi:10.1093/humrep/del127 · Cited by 281
Garcia-Velasco, J. A., Moreno, L., Pacheco, A., Guillén, A., Duque, L., Requena, A., & Pellicer, A. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.01.117 · Cited by 266
Eldar-Geva, T., Ben-Chetrit, A., Spitz, I. M., Rabinowitz, R., Markowitz, E., Mimoni, T., Gal, M., Zylber-Haran, E., & Margalioth, E. J. (2005) · Human Reproduction · doi:10.1093/humrep/dei203 · Cited by 255
Gonadotrophin-releasing hormone antagonists for assisted conception
Al-Inany, H. G., Abou-Setta, A. M., & Aboulghar, M. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001750.pub2 · Cited by 247
Efficacy of natural cycle IVF: a review of the literature
Pelinck, M. J. (2002) · Human Reproduction Update · doi:10.1093/humupd/8.2.129 · Cited by 243
Serum müllerian-inhibiting substance levels during normal menstrual cycles
Cook, C. L., Siow, Y., Taylor, S., & Fallat, M. E. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00639-1 · Cited by 237
Slopes of a Receiver Operating Characteristic Curve and Likelihood Ratios for a Diagnostic Test
Choi, B. C. K. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009591 · Cited by 199
Peñarrubia, J., Fábregues, F., Manau, D., Creus, M., Casals, G., Casamitjana, R., Carmona, F., Vanrell, J. A., & Balasch, J. (2005) · Human Reproduction · doi:10.1093/humrep/deh718 · Cited by 199
Anti‐müllerian hormone as a marker of ovarian reserve*
TREMELLEN, K. P., KOLO, M., GILMORE, A., & LEKAMGE, D. N. (2005) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2005.00332.x · Cited by 194
La Marca, A., Malmusi, S., Giulini, S., Tamaro, L. F., Orvieto, R., Levratti, P., & Volpe, A. (2004) · Human Reproduction · doi:10.1093/humrep/deh508 · Cited by 191
Massin, N., Cédrin‐Durnerin, I., Coussieu, C., Galey, J., Wolf, J., & Hugues, J. (2006) · Human Reproduction · doi:10.1093/humrep/dei481 · Cited by 147
Nakahara, K., Saito, H., Saito, T., Ito, M., Ohta, N., Takahashi, T., & Hiroi, M. (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)81521-x · Cited by 139
Rice, S., Ojha, K., Whitehead, S. A., & Mason, H. D. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1697 · Cited by 128
Nakahara, K., Saito, H., Saito, T., Ito, M., Ohta, N., Sakai, N., Tezuka, N., Hiroi, M., & Watanabe, H. K. (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)81915-2 · Cited by 120
Fleming, R., Harborne, L., MacLaughlin, D. T., Ling, D., Norman, J. E., Sattar, N. A., & Seifer, D. B. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.05.098 · Cited by 106
Self-citationBalasch, J., Fábregues, F., Peñarrubia, J., Carmona, F., Casamitjana, R., Creus, M. T., Manau, D., Casals, G., & Vanrell, J. A. (2006) · Human Reproduction · doi:10.1093/humrep/del052 · Cited by 104
Serum anti-Müllerian hormone expression in women with premature ovarian failure
Méduri, G., Massin, N., Guibourdenche, J., Bachelot, A., Fiori, O., Kuttenn, F., Misrahi, M., & Touraine, P. A. (2006) · Human Reproduction · doi:10.1093/humrep/del346 · Cited by 95
Oosterhuis, G., Michgelsen, H. W. B., Lambalk, C. B., Schoemaker, J., & Vermes, I. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00266-0 · Cited by 90
Outcome of in-vitro fertilization through natural cycles in poor responders
Bassil, S. (1999) · Human Reproduction · doi:10.1093/humrep/14.5.1262 · Cited by 84
Fleming, R., Deshpande, N., Traynor, I., & Yates, R. W. S. (2006) · Human Reproduction · doi:10.1093/humrep/dei499 · Cited by 69
Self-citationModi, D. N., Bhartiya, D., & Puri, C. P. (2006) · Reproduction · doi:10.1530/rep.1.01178 · Cited by 62
Elizur, S. E., Aslan, D., Shulman, A., Weisz, B., Bider, D., & Dor, J. (2005) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-005-1496-2 · Cited by 59
Effects of Aging on Ovarian Fecundity in Terms of the Incidence of Apoptotic Granulosa Cells
Sadraie, S. H., Saito, H., Kaneko-Tarui, T., Saito, T., & Hiroi, M. (2000) · Journal of Assisted Reproduction and Genetics · doi:10.1023/a:1009422323306 · Cited by 49
Cited by
The physiology and clinical utility of anti-Müllerian hormone in women
Dewailly, D., Andersen, C. Y., Balen, A., Broekmans, F., Dilaver, N., Fanchin, R., Griesinger, G., Kelsey, T. W., La Marca, A., Lambalk, C., et al. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmt062 · Cited by 1,049
Self-citationAnti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)
La Marca, A., Sighinolfi, G., Radi, D., Argento, C., Baraldi, E., Artenisio, A. C., Stabile, G., & Volpe, A. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmp036 · Cited by 956
De Vos, M., Devroey, P., & Fauser, B. C. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60355-8 · Cited by 763
La Marca, A., & Sunkara, S. K. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmt037 · Cited by 586
Broer, S. L., Dolleman, M., Opmeer, B. C., Fauser, B. C., Mol, B. W., & Broekmans, F. J. M. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmq034 · Cited by 485
Metadata
- Authors
- Nelson, S. M., Yates, R. W., & Fleming, R.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-06-28
- Volume
- 22
- Issue
- 9
- Pages
- 2414-2421
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2137497858
- Cited by
- 391
- References
- 44
- FWCI
- 18.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.